MALDI Biotyper based rapid resistance detection by stable isotope

Size: px
Start display at page:

Download "MALDI Biotyper based rapid resistance detection by stable isotope"

Transcription

1 JCM Accepts, published online ahead of print on 4 September 2013 J. Clin. Microbiol. doi: /jcm Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 MALDI Biotyper based rapid resistance detection by stable isotope labeling Katrin Sparbier 1, Christoph Lange 1, Jette Jung 2, Andreas Wieser 2, Sören Schubert 2, Markus Kostrzewa 1 1 BrukerDaltonik GmbH, Bremen, Germany 2 Max von Pettenkofer-Institut, Ludwig-Maximilians-Universität, Munich, Germany Running title: MALDI-TOF resistance profiling Keywords: MALDI-TOF MS, stable isotope labeling, resistance, Staphylococcus aureus, Oxacillin Corresponding author: Markus Kostrzewa BrukerDaltonik GmbH Fahrenheitstr Bremen 19 Germany 20 Tel.: * Fax: *

2 22

3 23 Abstract Against the background of increasing numbers of resistant microorganisms the fast and costefficient detection of microbial resistance is an important clinical requirement for optimal therapeutic intervention. Current routine assays take at least 5 h but in most cases an overnight incubation is necessary to identify resistant isolates. The usage of MALDI-TOF MS profiling in combination with growth media containing isotopically labeled amino acids facilitates the detection of resistant microorganisms already after 3 h or less directly from the profile spectrum. Growing microorganisms incorporate isotopically labeled amino acids, increasing protein masses and thereby leading to mass shifts of their corresponding peaks in profile spectra. In the presence of antibiotics only resistant microorganisms are able to grow and to incorporate the labeled amino acids. This leads to a difference in the mass spectra of susceptible and resistant isolates allowing for their differentiation. In the presented study, we demonstrated the applicability of this novel approach for the detection of methicillin resistant Staphylococcus aureus and tested different bioinformatics approaches for automated data interpretation.

4 42 Introduction The intensive use of antibiotic drugs leads to an increasing number of microorganisms resistant against these antibiotics. Only the specific and restricted use of antibiotics can help to curtail this problem (1). An important prerequisite for the correct choice of the therapeutic intervention is the rapid detection of resistant strains. Common routine methods are based either on automated microbiology systems such as Phoenix (BD Diagnostic Systems, Heidelberg, Germany), MicroScan (Siemens Healthcare Diagnostics GmbH, Eschborn, Germany ) or Vitek 2 (biomérieux, Nürtingen, Germany) (2),(3), which determine the MIC by monitoring the growth of bacteria and are able to provide results after about 5 h for rapid growing organisms, or on agar diffusion assays generally requiring an overnight incubation. Recently, Matrix-assisted laser-desorption/ionization mass spectrometry(maldi-tof MS) has become a routine method in microbiology laboratories for the identification of microorganism (4 6). For example, the comparison of a profile spectrum acquired from a microorganism with profile signatures stored in a respective reference library allows for the quick and reliable species determination (MALDI Biotyper system, Bruker Daltonik GmbH, Germany). Additionally, MALDI-TOF MS has recently been applied for the detection of ß- lactamase activity providing resistance against ß-lactam antibiotics in gram-negative microorganisms (7 9). This approach, which is a first promising step towards MALDI-TOF resistance detection, monitors the hydrolysis of the respective antibiotic in the presence of the bacteria to be tested. Thereby, it delivers a classification of bacteria according to their ß- lactamase hydrolysis activity within 2 3h (7 9). Unfortunately, this assay is only applicable to detect resistance against ß-lactam antibiotics and in addition, negative results cannot definitely be interpreted as susceptible for all bacteria. Alternative resistance mechanisms might hide the ß-lactamase activity. On the other hand it can be a rapid and cost-effective tool for observation of the spread of ß-lactamase carrying bacteria in hygiene monitoring, e.g. for KPC (Klebsiella pneumoniae carbapenemase).

5 To overcome the restriction of detection of only a single resistance mechanism and to extend mass spectrometric resistance testing also to other than ß-lactam antibiotics, a novel approach was established. This approach is based on the knowledge that growing cells perform protein biosynthesis. The exchange of naturally occurring amino acids with their nonradioactive isotopically labeled versions in a growth medium leads to the incorporation of these heavy amino acids into the newly synthesized proteins. This results in mass shifts of the peaks in the profile mass spectrum of a microorganism. During incubation of bacteria in the presence of antibiotics, resistant strains are still able to grow and to newly synthesize heavy proteins. These proteins are detectable as characteristic peak shifts in the profile spectrum. Susceptible strains do not or only slowly grow under such conditions, resulting in a profile spectrum most similar to the normal profile spectrum of these strains. Thereby, the changes in the profile spectrum should function as indicator for the discrimination between susceptible and resistant strains. In this paper, the novel MALDI-TOF MS based resistance test with stable isotopes (MS- RESIST) is described and its applicability for the classification of Methicillin susceptible Staphylococcus aureus (MSSA) and Methicillin resistant Staphylococcus aureus (MRSA) as model system is demonstrated. First approaches to a bioinformatics data interpretation are shown. Material and methods Bacterial strains and cultivation Clinical isolates of Staphylococcus aureus (Max von Pettenkofer-Institute, Munich, Germany) previously classified by standard routine methods as MRSA and MSSA strains were employed as positive and negative samples (10 negative and 10 positive strains), respectively. MRSA strains were characterized as non-borsa strains by detecting the meca gene and phenotypically a resistance against cefoxitin. Twenty-eight further clinical isolates

6 of Staphylococcus aureus were obtained from the Praxis für Laboratoriumsmedizin, Ärztliche Gemeinschaft für Diagnostik Köln Bonn, Germany. These were used blinded during the analysis. The molecular characterization is given in the supplementary material. Bacteria were cultivated on Columbia blood agar plates (BD, Germany) without selective agents over night at 37 C. Fresh overnight cultures were employed for the tests Resistance profiling assay Dulbecco s modified Eagle medium with low glucose and without lysine, arginine, and leucine (Sigma Aldrich, Germany) was supplemented with all proteinogenic amino acids (Sigma Aldrich, Germany) except of lysine at a concentration of 0.3 g/l, with sodium chloride (4%, Sigma Aldrich, Germany), 4 g/l glucose (Sigma Aldrich, Germany), and 60 mg/l iron- (II) chloride (Sigma Aldrich, Germany). For each strain, three different 100 µl-setups were prepared: normal containing 0.1 g/l normal lysine (Sigma-Aldrich, Germany), heavy containing 0.1 g/l 13 C 15 6 N 2 -L-lysine (Fisher Scientific, Germany), and heavy + Oxa containing 0.1 g/l 13 C 15 6 N 2 -L-lysine and 60 mg/l Oxacillin (Sigma-Aldrich, Germany), respectively. Each medium preparation was inoculated with bacteria of the same strain at a final cell concentration of 3.5x10 6 cells per ml. The bacterial suspensions were incubated at 37 C under agitation in a thermomixer (Eppendorf, Germany) for three hours. After incubation, the cells were centrifuged and washed with 150 µl pure water. Subsequently, bacteria were lysed with 10 µl 70% formic acid and 10 µl of 100 % acetonitrile according to the MALDI Biotyper standard extraction protocol for bacterial profiling (10). Similar experiments were performed with 40 mg/l cefoxitin (Sigma-Aldrich, Germany) instead of Oxacillin. 116 MALDI-TOF MS analysis One µl of the cell-free lysates was directly spotted onto a polished steel MALDI target plate. Each lysate was spotted four times. Dried spots were overlaid with MALDI matrix (α-hcca, 10mg/mL of α-cyano-4-hydroxy-cinnamic acid in 50% acetonitrile/2.5% trifluoroacetic acid; BrukerDaltonik, Bremen). After drying of the matrix, MALDI-TOF MS measurements were

7 performed with a microflex LT/SH bench-top mass spectrometer (BrukerDaltonik GmbH, Bremen) equipped with a 60 Hz nitrogen laser. Parameter settings had been optimized for the mass range between ,000 Da (parameter settings: ion source 1 (IS1), 20 kv; IS2, 17.5 kv; lens, 6.5 kv; detector gain, 7.4 V; and gating: none). Spectra were recorded in the positive linear mode with the maximum laser frequency. An external standard (Bacterial test standard (BTS), Bruker Daltonik GmbH, Bremen) was used for instrument calibration. Data evaluation Different data evaluation procedures were applied. First, spectra were visually compared to search for peak shifts using flexanalysis 3.4 (Bruker Daltonik GmbH, Bremen) and ClinProTools 3.0 (Bruker Daltonik GmbH, Germany). Additionally, automated spectra analysis was performed with the MALDI Biotyper 3.1 software (Bruker Daltonik GmbH, Bremen) using the integrated calculation of the correlation index matrix applying the standard settings of the software considering the mass range between 3,000 to 12,000 Da (correlation analysis). Strains comprising a correlation index for the normal spectra versus the heavy + antibiotic spectra similar or below 0.6 were classified as resistant. Heavy spectra served as a control for growth. For alternative automated evaluation approaches, specific peaks were chosen for normal and heavy peaks. The sums of their intensities were changing their ratio during growth in the presence of isotopically labeled amino acids. The following masses were chosen as normal peaks: , , , , , , , , and Da. The following masses additionally found in the heavy spectra were chosen as heavy peaks: , , , , , , , , , , and Da. The ratio of the summarized peak intensities of the heavy peaks and the summarized peak intensities of the normal peaks was calculated (ratio H/N). This ratio directly correlates with the incorporation of heavy amino acids (incorporation analysis). The four different results of each spectra group were displayed in a box plot indicating the median by the bold line, the minimum and the maximum by the whiskers, and the 25th and

8 th percentiles by the box. The incorporation analysis resulted in three different ratios (H/N) for each strain according to each medium, respectively Considering the ratios of the heavy + antibiotic spectra of the incorporation analysis revealed values similar or greater than 1.0 for resistant strains. For an additional evaluation procedure, the ratios of the incorporation analysis of the heavy spectra and the heavy + antibiotic spectra were subtracted and subsequently divided by the ratio (H/N) of the heavy spectra. This resulted in the normalized difference. Again, these results were displayed in a box plot. Strains with a normalized difference similar or below 0.5 were classified as resistant. The calculations of the incorporation analysis and the normalized duifference were performed with a software tool written in the freely available software package R (11), (12). All threshold values were empirically set and might be adapted when larger sample numbers will have been analyzed. Routine susceptibility testing of isolates for comparison The minimal inhibitory concentration (MIC) against Oxacillin and Cefoxitin were determined employing the Epsilometer test. Briefly, MIC Test Strips (Liofilchem, Italy) were placed on 85 mm Mueller Hinton agar plates (BD Diagnostics Systems), which had been inoculated with a 0.5 McFarland standard suspension of test isolates. All plates were incubated at 37 C for 20 to 24 h before being examined. The MIC was determined to be the value at which the elliptical growth margin intersected the MIC Test strip. The evaluation of resistance status was performed according to the current CLSI guideline CLSI M100-S21 aerobic bacteria Results 171 Principle of the assay

9 In first experiments, the principle of the mass spectrometric resistance test with stable isotopes (MS-RESIST) assay was investigated. Four known MSSA and four known MRSA strains were incubated for 3h under the above described conditions. Each strain was incubated with normal amino acids ( normal ), with isotopically labeled amino acids ( heavy ), and with isotopically labeled amino acids plus antibiotics ( heavy + Oxa ) for 3 h, respectively. After washing and lysing of the cells, MALDI-TOF MS spectra were acquired. The subsequent spectra analysis revealed clear differences in the three spectrum sets. Figure 1 shows a zoom of representative single spectra shown in Flexanalysis (A, B) and the pseudo-gel views in ClinProTools (C, D) of the three different setups ( normal, heavy, heavy + Oxa ) for one of the susceptible strains (A, C) and one of the resistant strains (B, D), respectively. For both strains the heavy spectra contain additional peaks not detectable in the normal spectra (Fig. 1A, 1B, boxes). In addition, peaks present in the normal spectra are reduced in intensity or even absent in the heavy spectra (Fig. 1A, 1B, grey underlay). Analyzing the heavy + Oxa spectra, revealed differences in the relative peak intensities of heavy to normal peaks between the susceptible and the resistant strains. The heavy + Oxa spectrum of the resistant strain is nearly identical to the corresponding heavy spectrum. This is an indication of growth and protein biosynthesis virtually not affected by the antibiotic. In contrast, the heavy+oxa spectra of the susceptible strains were more similar to the normal spectra than to the heavy spectra. This indicates a clearly reduced protein synthesis through the antibiotic action. The ratio of the peak intensities of the normal to the heavy peaks was quite different in the heavy + Oxa spectrum of the susceptible strain. The normal peaks in the heavy + Oxa spectrum were relatively increased compared to the normal peaks in the heavy spectrum and the heavy peaks were decreased compared to the heavy peaks in the heavy spectrum. The display of the spectra in ClinProTools (Fig. 1C, 1D) allows for a direct comparison of the peak intensities because this software normalizes spectra to the total ion count. Additionally, the variance between the different spectra belonging to one set can be easily monitored. In this view, the peaks are displayed as bands and the peak intensities are given as grey scale. The

10 comparison between the normal and the heavy spectra shows the maximum change in the peak pattern which resulted from the incorporation of heavy amino acids by growing cells. As expected, no significant differences can be found between the susceptible and the resistant strain. In contrast, the heavy + Oxa spectra exhibit a different pattern for a susceptible and a resistant strain. In case of the resistant strain (Fig. 1D), the heavy + Oxa spectra look very similar to the heavy spectra. On the other hand, the heavy + Oxa spectra of the susceptible strain (Fig. 1C) show their individual peak pattern, still similar to the normal spectra. In the heavy + Oxa spectra, normal peaks are more intense than the respective peaks in the heavy spectra. In contrast, peaks resulting from the incorporation of heavy amino acids are considerably reduced in their intensities compared to the respective peak intensities of the heavy spectra. The observed relative changes of the peak intensities in the heavy + Oxa spectra compared to the heavy spectra correlated with the reduced growth of the susceptible strains in the presence of the antibiotic and could be used as a measure for the discrimination between susceptible and resistant strains. Using Cefoxitin instead of Oxacillin led to similar results. Figure 2 represents single spectra displayed in FlexAnalysis (A,B) and the pseudo-gel views displayed in ClinProTools (C,D) of a susceptible and a resistant strain. Changes in peak pattern result in reduced spectra similarity which can be calculated by correlation analysis and displayed in a composite correlation index matrix (CCI matrix). Correlation analysis is an established method to compare spectra similarities. Figure 3 shows the CCI matrices of the susceptible (A) and the resistant (B) Staphylococcus aureus strains analyzed before. For the susceptible strain, a correlation index of about 0.7 was calculated for the correlation between the heavy versus the heavy + Oxa spectra (Fig. 3A). A similar index was calculated for the correlation of normal versus heavy + Oxa spectra. This means, that the heavy + Oxa spectra represent similarity to the normal spectra as well as to the heavy spectra. The heavy + Oxa spectra seem to represent the average spectrum of the normal and the heavy spectra. This result was in concordance with the visual analysis using flexanalysis and ClinProTools. For the resistant strain (Fig.

11 B), the correlation indices were quite different. The correlation between the heavy versus heavy + Oxa spectra was very strong, represented by a correlation index above 0.9. In contrast, the correlation between the heavy + Oxa and the normal spectra was quite poor, indicated by a correlation index below 0.6. Again, these results were in good concordance to the visual analysis in flexanalysis and ClinProTools Further bioinformatic methods were developed in order to get defined values which allow for a direct comparison of different strains and thereby, with the results from routine analyses. The incorporation analysis resulted in three different quotients for each strain (A corresponding figure is shown in the supplementary material, Fig. S1). The ratio (H/N) for the normal spectra was near to zero for all different strains because no heavy peaks were present in the spectra derived from growth in normal culture medium. The ratio (H/N) of the heavy spectra was a measure for the maximal incorporation of isotopically labeled amino acids and thereby an important control for the growth of the strains. This value differed somewhat for each of the strains regardless of the resistance status. The ratio (H/N) for heavy + Oxa spectra revealed clear differences for the susceptible and the resistant strains, respectively.the ratios (H/N) were below 1.0 for all susceptible strains. In contrast, the incorporation analysis of the heavy + Oxa spectra of the resistant strains revealed values in the same range as the values of heavy spectra and clearly exceeded 1.0. In the next step, the normalized differences were calculated for each strain (a respective figure is shown in the supplementary materialand Fig. S2). Again, a clear separation between the susceptible and the resistant strains was observed. All susceptible strains revealed a normalized difference above 0.5 and the resistant strains showed normalized differences below Day-to-day reproducibility The reproducibility of the mass spectrometric analysis was investigated by analyzing four strains comprising two susceptible and two resistant strains, respectively, on three different days. The visual inspection of the resulting spectra allowed for a correct classification of the

12 strains according to resistance or susceptibility for all replicates and every day. For an automated classification, the spectra sets were analyzed with the three different evaluation approaches (Fig. 4). Calculation of the correlation index of the heavy + Oxa spectra versus the normal spectra revealed only one misclassification. The detailed analysis on the spectra level showed that these spectra comprise a stronger noise compared to other spectra. This reduced the similarity to all other spectra, the heavy and the normal spectra. All other results were in agreement with the expected results (Fig 4A). The incorporation analysis of the heavy + Oxa spectra was in agreement with the expected classification (Fig. 4B). Only for one of the resistant strains, the achieved classification did not agree with the expected one on day three. The detailed analysis of this strain revealed that the ratios (H/N) of the heavy and the heavy + Oxa spectra were both in the same range but relatively low. This means that the growth of this strain was poor on day three. The calculation of the normalized difference revealed complete concordance with the expected classification for all strains on all analysis days (Fig. 4C). Analysis of routine samples In the following, the novel approach was applied to routine samples of Staphylococcus aureus and the outcome was compared to the results of the MIC determination. In total, 28 strains were analyzed. Table 1 lists the results of the routine testing and the results of the MALDI-TOF MS analyses for Oxacillin and Cefoxitin, respectively. For all spectra sets, the three different evaluation procedures were performed. The results of the automated evaluations (correlation analysis, incorporation analysis of heavy + antibiotic spectra, and calculation of the normalized differences) of the mass spectra were mostly in accordance to the routine results. For strain 260, the calculation of the normalized differences resulted in values which were below the threshold values for susceptible strains resulting in the classification resistant, although this strain was classified by other approaches and the routine method as susceptible. The detailed analysis of the underlying incorporation

13 analysis revealed a very low value for the heavy spectra meaning a very poor growth of this strain. The correlation analysis of the cefoxitin approaches resulted in three cases in a misclassification. The detailed visual inspection of the spectra revealed increased noise in the underlying spectra resulting in decreased similarity to the corresponding normal spectra. All other strains were classified in concordance to the different evaluation procedures for the mass spectrometric data and to the routine results, with all applied bioinformatics algorithms. Discussion The principle of the new approach for resistance detection is based on the incorporation of non-radioactive isotopically labeled amino acids into newly synthesized proteins during growth of cells. The isotopically modified proteins lead to an increased molecular weight of the peptides and proteins detectable by a mass shift in the MALDI-TOF profile spectra. In the presence of antibiotics only resistant cell are able to grow and to perform protein biosynthesis. Susceptible strains stop growing under antibiotic stress and thereby present different profile spectra compared to the setups without antibiotics. Recently, a comparable approach has been published by Demirev et. al.(13). In contrast to this study, they employed completely 13 C labeled culture medium resulting in multiple peak shifts with different mass differences which were determined by the number of carbons within the respective peptide/protein. In addition to the high cost for the culture medium, the evaluation becomes more complicated by this approach. In contrast, in the study presented here, a protocol and different data evaluation approaches were developed based on the incorporation of single isotopically labeled amino acids. The resulting peak shifts in the profile spectra of Staphylococcus aureus strains were monitored and employed for a subsequent classification SILAC (stable isotope labeling by/with amino acids in cell culture) is a common technique for quantitative proteomics [12]. Pre-configured cell culture media without certain amino acids,

14 e.g. lysine, arginine, and leucine, are commercially available. For this work, only lysine was chosen as isotopic amino acid. Lysine occurs frequently in ribosomal proteins which are the main proteins detected in the MALDI Biotyper profile spectra (14, 15). Employing another amino acid as isotopic marker led to different changes in the profile spectra (data not shown). To establish the procedure, a small set of Staphylococcus aureus strains with known resistance properties was analyzed with this approach. Different concentrations of heavy amino acids were tested (data not shown). The concentration used in this work is a compromise between outcome and costs. Additionally, the incubation time was optimized. An incubation time of 2.5 h already allowed a classification for fast growing strains but not for all strains. The reason for this is on the one hand a lag phase before the cells start growing and on the other hand the presence of the proteins from the starting material comprising normal proteins. Several cell divisions were necessary to reduce the relative amount of the normal proteins to get sufficient intensities of the peaks corresponding to the heavy proteins. Further, even the susceptible strains do not immediately stop producing new proteins in the presence of oxacillin or cefoxitin but get slowed down by time. Therefore, a sufficient incubation time is required to facilitate the discrimination between susceptible and resistant strains. Thus, the set up with the heavy amino acids without antibiotics is an important control because this set up represents the maximal possible growth of a respective strain. An incubation time of 3 h was found to be sufficient and was applied in all experiments. The visual inspection on the spectra level is very time consuming and not suitable for the analysis of many spectra. Therefore, different automated evaluation approaches were applied to the spectra. Correlation analysis calculates the similarity between the different spectra sets. A breakpoint had to be defined to get a clear separation between the resistant and the susceptible strains. Since the susceptible strains still perform protein biosynthesis, the heavy + antibiotic spectra comprise normal as well as heavy peaks resulting in similarities to the normal spectra and to the heavy spectra. A correlation index below 0.6 of the comparison between heavy + antibiotic and normal spectra clearly indicated for a resistant strain. Applying this approach to the day-to-day reproducibility test and to 28

15 unknown samples revealed good concordance with the routine results. In some experiments (Fig 4C, strain 4, day 3, strain 260/FOX, Strain 469/FOX, strain 32241/FOX), this approach led to wrong classifications. The investigation on the spectra level revealed that in these cases the quality of the heavy + antibiotic spectra was poor. Strong noise resulted in dissimilarity to the normal as well as to the heavy spectra. This experiment demonstrates the importance of consistent spectra quality to get correct classifications by correlation analyses. The incorporation analysis is based on the pre-definition of peaks deriving from the normal and from heavy peaks within a spectrum, respectively. The ratio of the added intensities of the heavy peaks to the added intensities of the normal peaks was taken as a measure for the growth. High score values correspond to a growing culture. When susceptible strains were cultured in the presence of antibiotics this value was decreased compared to nonsusceptible strains. A breakpoint of 1.0 for the incorporation of heavy lysine in the heavy + antibiotic spectra was found to be suitable for the separation of susceptible and resistant strains. Susceptible strains revealed a value below 1.0 for the heavy + antibiotic spectra. The evaluation of the spectra sets according to this method led to the correct classification of all strains but one. In this experiment (Fig 4A, strain1, day 3) one of the resistant strains showed a value below the previously defined breakpoint. Investigating this result revealed poor growth of this strain in all set ups. Applying the calculation of the normalized difference also revealed good concordance with the routine results. One strain of the unknown clinical isolates was misclassified. The visual inspection of the spectra allowed for a clear classification as susceptible strain. The analysis of more strains and strict standardization will be necessary to confirm the suggested breakpoints and to facilitate the handling of strains comprising intermediate resistance behavior. In general, the approach presented in this study could be applied to classify Staphylococcus aureus strains according to their resistance status. The use of different antibiotics led to similar classifications. The visual inspection on the spectra level allowed for a correct classification of all strains analyzed, in each experiment. The correlation analysis failed in few cases. The reasons for the failure

16 were either on the technical side, e.g.the spectra quality or on the biological side, e.g. the growth of the microorganisms. Therefore, an optimization, adaptation, and further development of the analysis tools will be necessary. Considering that the incorporation analysis and the normalized difference are species specific tools, the development of a species independent analysis algorithm might be preferred Compared to other resistance assays this approach is very quick. Results could be read out after h comprising 3 h for the incubation of the cells and the residual time for setting up the assay, the subsequent sample preparation, the acquisition of spectra, and the evaluation. For other microorganisms and antibiotics even significantly shorter analysis times could be achieved (work in progress, data not shown). Most routine assays need an overnight incubation and automated resistance detection systems need at least 5 h for fast growing bacteria before a result can be stated. In the case that MALDI Biotyper based identification of microorganisms has already been established in a lab, no additional technical equipment would be necessary to perform this resistance test. The readout is directly based on the classical profile spectra which are acquired in the same mode as spectra for species identification. The combination of MALDI-TOF MS identification and MS- RESIST testing as described here might enable identification and resistance testing in a single day on the same equipment.in contrast to the MSBL assay (mass spectrometric ß- lactamase assay) (7 9), this approach could be applied to different antibiotics additionally to ß-lactam antibiotics and might be able to detect all known resistance mechanisms (16, 17). Preliminary results have already demonstrated that this technique can also be applied to investigate Meropenem resistance in Klebsiella pneumoniae and Pseudomonas aeruginosa and aminoglycoside resistance in Pseudomonas aeruginosa (data not shown, Jung et. al, manuscript in preparation). In principle, the MS-RESIST assay might be generally applicable to different species, also including fungi, and to other antibiotics. Optimal incubation conditions like time, adaptation of the culture medium and antibiotic concentration will have to be tested for the respective approach. Different alternative evaluation procedures might be necessary for optimal results of different species and antibiotic combinations.

17 Transparency declaration Katrin Sparbier, Christoph Lange, and Markus Kostrzewa are employed at the mass spectrometry company Bruker Daltonik GmbH, Bremen, Germany Literature 1. Leone M, Martin C How to break the vicious circle of antibiotic resistances? Curr Opin Crit Care 14: Bou G Minimum inhibitory concentration (MIC) analysis and susceptibility testing of MRSA. Methods Mol. Biol. 391: Woodford N, Eastaway AT, Ford M, Leanord A, Keane C, Quayle RM, Steer JA, Zhang J, Livermore DM Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J. Clin. Microbiol. 48: Mellmann A, Bimet F, Bizet C, Borovskaya AD, Drake RR, Eigner U, Fahr AM, He Y, Ilina EN, Kostrzewa M, Maier T, Mancinelli L, Moussaoui W, Prévost G, Putignani L, Seachord CL, Tang YW, Harmsen D High interlaboratory reproducibility of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based species identification of nonfermenting bacteria. J. Clin. Microbiol. 47: Sauer S, Kliem M Mass spectrometry tools for the classification and identification of bacteria. Nat. Rev. Microbiol. 8: Seng P, Rolain J-M, Fournier PE, La Scola B, Drancourt M, Raoult D MALDI- TOF-mass spectrometry applications in clinical microbiology. Future Microbiol 5: Sparbier K, Schubert S, Weller U, Boogen C, Kostrzewa M Matrix-assisted laser desorption ionization-time of flight mass spectrometry-based functional assay for rapid detection of resistance against β-lactam antibiotics. J. Clin. Microbiol. 50: Hrabák J, Walková R, Studentová V, Chudácková E, Bergerová T Carbapenemase activity detection by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 49: Burckhardt I, Zimmermann S Using matrix-assisted laser desorption ionizationtime of flight mass spectrometry to detect carbapenem resistance within 1 to 2.5 hours. J. Clin. Microbiol. 49: Sauer S, Freiwald A, Maier T, Kube M, Reinhardt R, Kostrzewa M, Geider K Classification and identification of bacteria by mass spectrometry and computational analysis. PLoS ONE 3:e R: A language and environment for statistical computing. Vienna, Austria. 12. Gibb S, Strimmer K MALDIquant: a versatile R package for the analysis of mass spectrometry data. Bioinformatics 28: Demirev PA, Hagan NS, Antoine MD, Lin JS, Feldman AB Establishing Drug Resistance in Microorganisms by Mass Spectrometry. J. Am. Soc. Mass Spectrom. 14. Teramoto K, Sato H, Sun L, Torimura M, Tao H A simple intact protein analysis by MALDI-MS for characterization of ribosomal proteins of two genomesequenced lactic acid bacteria and verification of their amino acid sequences. J. Proteome Res. 6:

18 Teramoto K, Sato H, Sun L, Torimura M, Tao H, Yoshikawa H, Hotta Y, Hosoda A, Tamura H Phylogenetic classification of Pseudomonas putida strains by MALDI- MS using ribosomal subunit proteins as biomarkers. Anal. Chem. 79: Poole K Efflux pumps as antimicrobial resistance mechanisms. Ann. Med. 39: Tenover FC Mechanisms of antimicrobial resistance in bacteria. Am. J. Med. 119:S3 10; discussion S Downloaded from on April 21, 2018 by guest

19 449 Figure legends 450 Figure Zoom of MALDI-TOF MS spectra displayed in flexanalysis (A, B) and ClinProTools (C, D) in the mass range between 6200 and 7200 Da of a susceptible Staphylococcus aureus strain (A, C) and a resistant Staphylococcus aureus strain (B, D) after incubation with normal lysine ( normal ), with heavy lysine ( heavy ), and with heavy lysine and Oxacillin ( heavy + Oxa ), respectively. Peaks corresponding to normal proteins are highlighted in light grey (A, B). Peaks corresponding to heavy proteins are indicated by the boxes (A, B). Y-axes give the number s of multiple measurements (C, D). Figure 2 Zoom of MALDI-TOF MS spectra displayed in flexanalysis (A, B) and ClinProTools (C, D) in the mass range between 6200 and 7200 Da of a susceptible Staphylococcus aureus strain (A, C) and a resistant Staphylococcus aureus strain (B, D) after incubation with normal lysine ( normal ), with heavy lysine ( heavy ), and with heavy lysine and Oxacillin ( heavy + FOX ), respectively. Peaks corresponding to normal proteins are highlighted in light grey (A, B). Peaks corresponding to heavy proteins are indicated by the boxes (A, B). Y-axes give the number s of multiple measurements (C, D). 470 Figure Correlation analysis: Correlation matrix of normal versus heavy + Oxa versus heavy of a susceptible strain (A) and a resistant strain (B). Red means strong similarity and blue means low similarity. Values similar or below 0.6 for the correlation normal versus heavy + Oxa were considered as resistant.

20 Figure Reproducibility of the MS-RESIST assay in combination with the different automated data evaluation strategies shown for four different Staphylococcus aureus strains (22318, 55158, 55279, and 56838) and Oxacillin Downloaded from on April 21, 2018 by guest

21 _N 0:C2 MS, Smoothed, BaselineSubtracted Intens. [a.u.] Intens. [a a.u.] Intens. [a.u.] x x x A normal _H_60 0:C10 MS, Smoothed, BaselineSubtracted heavy + Oa Oxa _H 0:C5 MS, Smoothed, BaselineSubtracted heavy Intens. [a.u.] Intens. [a a.u.] Intens. [a.u.] x x x B _N 0:E2 MS, Smoothed, BaselineSubtracted normal _H 0:E7 MS, Smoothed, BaselineSubtracted heavy + Oa Oxa _H_60 0:E9 MS, Smoothed, BaselineSubtracted heavy C normal D normal heavy + Oxa heavy + Oxa heavy heavy Figure 1: Zoom of MALDI-TOF MS spectra displayed in flexanalysis (A, B) and ClinProTools (C, D) in the mass range between 6200 and 7200 Da of a susceptible Staphylococcus aureus strain (A, C) and a resistant Staphylococcus aureus strain (B, D) after incubation with normal lysine ( normal ), with heavy lysine ( heavy ), and with heavy lysine and Oxacillin ( heavy + Oxa ), respectively. Peaks corresponding to normal proteins are highlighted in light grey (A, B). Peaks corresponding to heavy proteins are indicated by the boxes (A, B). Y-axes give the number s of multiple measurements (C, D).

22 449_N 0:H1 MS, Smoothed, BaselineSubtracted Intens. [a.u.] Intens. [a.u.] Intens. [a.u.] x x x A normal 449_H_60 0:H6 MS, Smoothed, BaselineSubtracted heavy + FOX 449_H 0:H3 MS, Smoothed, BaselineSubtracted heavy Intens. [a.u.] Intens. [a.u.] Intens. [a.u.] x x x B 330_N 0:E2 MS, Smoothed, BaselineSubtracted normal 330_H_60 0:E6 MS, Smoothed, BaselineSubtracted heavy + FOX 330_H 0:E3 MS, Smoothed, BaselineSubtracted heavy C normal D normal heavy + FOX heavy + FOX heavy heavy Figure 2: Zoom of MALDI-TOF MS spectra displayed in flexanalysis (A, B) and ClinProTools (C, D) in the mass range between 6200 and 7200 Da of a susceptible Staphylococcus aureus strain (A, C) and a resistant Staphylococcus aureus strain (B, D) after incubation with normal lysine ( normal ), with heavy lysine ( heavy ), and with heavy lysine and Oxacillin ( heavy + FOX ), respectively. Peaks corresponding to normal proteins are highlighted in light grey (A, B). Peaks corresponding to heavy proteins are indicated by the boxes (A, B). Y-axes give the number s of multiple measurements (C, D).

23 A susceptible strain 0,34 0,73 1,00 3: normal 0,72 1,00 0,73 2: heavy + Oxa 1,00 0,72 0,34 1: heavy Low similarity B resistant strain 0,34 0,40 1,00 3: normal 0,97 1,00 0,40 2: heavy + Oxa 1,00 0,97 0,34 1: heavy High similarity Downloaded from Figure 3 Correlation analysis: Correlation matrix of normal versus heavy + Oxa versus heavy of a susceptible strain (A) and a resistant strain (B). Red means strong similarity il it and blue means low similarity. il it Values similar il or below 0.6 for the correlation normal versus heavy + Oxa were considered as resistant. on April 21, 2018 by guest

24 A tion index Correla B Correlation analysis "heavy + Oxa" versus "normal" Incorporation analysis of "heavy + Oxa Day 1 Day 2 Day 3 C Normalize ed Difference Normalized Difference Day 1 Day 2 Day 3 Downloaded from f "heavy + OXA" Ratio (H/N) o Day 1 Day 2 Day 3 Figure 4 Reproducibility of the MS-RESIST assay in combination with the different automated data evaluation strategies shown for four different Staphylococcus aureus strains (22318, 55158, 55279, and 56838) and Oxacillin. on April 21, 2018 by guest

25 Table 1: Results of resistance testing by the standard routine method and the different bioinformatics approaches applied to the MS-RESIST spectra for the 28 routine isolates. Bold indicates resistance. Italic indicates dissent with other classification results. N/A: no spectra acquired. Correlation Incooperation Correlation Incooperation Normalized Normalized MIC [µg/ml] MIC [µg/ml] analysis "Heavy analysis analysis "Heavy Strain analysis "Heavy Difference Difference Oxacillin Cefoxitin +Oxa"/ "Heavy + + FOX"/ + Oxa" Oxa FOX "Normal" FOX" "Normal" >= 4 (R) >= 4 (R) >= 1 (R) <= 0.5 (R) <= 0.6 (R) >= 1 (R) <= 0.6 (R) <= 0.6 (R)

26 (4)

27 N/A N/A N/A

28 Number of resistant 14/28 14/28 14/28 15/28 14/28 13/27 14/27 16/27 strains of total strains Downloaded from on April 21, 2018 by guest

Quantitative MALDI-TOF MS for Rapid Resistance Detection

Quantitative MALDI-TOF MS for Rapid Resistance Detection JCM Accepts, published online ahead of print on 17 September 2014 J. Clin. Microbiol. doi:10.1128/jcm.01872-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 Quantitative MALDI-TOF

More information

Combatting AMR: diagnostics

Combatting AMR: diagnostics Combatting AMR: diagnostics Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Gonorrhoea: a paradigm for better diagnostics International

More information

Antimicrobial Susceptibility Testing

Antimicrobial Susceptibility Testing AST Antimicrobial Susceptibility Testing Marc V. Assous, MD, PhD Shaare Zedek Med. Ctr. Universite Paris Descartes The purpose To present the methods used for AST A - Micro-dilution (ISO 20776-2006) B

More information

rapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF

rapiflex Innovation with Integrity Designed for Molecules that Matter. MALDI TOF/TOF rapiflex Designed for Molecules that Matter. Innovation with Integrity MALDI TOF/TOF rapiflex TM The first MALDI-TOF/TOF that adapts to your needs. The rapiflex is the most advanced MALDI TOF/TOF system

More information

Biofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement

Biofilm Protocol Optimization For Pseudomonas aeruginosa. Introduction. Materials and Methods. Culture Media, Incubation Time, and Biofilm Measurement Biofilm Protocol Optimization For Pseudomonas aeruginosa Culture Media, Incubation Time, and Biofilm Measurement Introduction In addition to the conventional arsenal of antibiotic resistance mechanisms

More information

Rapid Bacterial Identification Using a Mass Spectrometry Based Molecular Diagnostics Approach: Evaluation of the Iridica Platform

Rapid Bacterial Identification Using a Mass Spectrometry Based Molecular Diagnostics Approach: Evaluation of the Iridica Platform Rapid Bacterial Identification Using a Mass Spectrometry Based Molecular Diagnostics Approach: Evaluation of the Iridica Platform Alec Saitman, PhD, Jane Y. Yang PhD, Sharon Reed, David Pride, Michele

More information

Ezy MIC Strip FEATURES AND ADVANTAGES

Ezy MIC Strip FEATURES AND ADVANTAGES Imipenem with & without EDTA Ezy MIC Strips (IPM+EDTA/IPM) (Imipenem + EDTA: 1-64 mcg/ml) (Imipenem : 4-256 mcg/ml) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM078 Not for Medicinal

More information

Abstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc

Abstract. Mary Jane Ferraro, PhD, MPH Jana M. Swenson, MMSc January 2009 Vol. 29 No. 2 Replaces M07-A7 Vol. 26 No. 2 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard Eighth Edition This document addresses

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Breakpoint Differences Cephalosporin Breakpoints for Enterobacteriaceae A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1

A Verification Study for Implementing the Revised CLSI Breakpoints. Summary. Glossary CDC 1 A Verification Study for Implementing the Revised CLSI Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance National Center for Emerging and Zoonotic Infectious Disease

More information

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18

ABC. Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline. Volume 19 Number 18 M26-A ISBN 1-56238-384-1 September 1999 ISSN 0273-3099 Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guideline Volume 19 Number 18 Arthur L. Barry, Ph.D. William A. Craig,

More information

Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution

Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution Rapid Peptide Catabolite ID using the SCIEX Routine Biotransform Solution Rapidly Identify Major Catabolites with the SCIEX X500R QTOF System and MetabolitePilot TM 2.0 Software Ian Moore and Jinal Patel

More information

Multidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015?

Multidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015? Analysis. Answers. Action. www.aphl.org Multidrug-Resistant Organisms: Where Are We with Detection and Reporting in 2015? Audrey N. Schuetz, MD, MPH 1 Faculty Disclosure The Association of Public Health

More information

Improved Monitoring of P. aeruginosa on Agar Plates

Improved Monitoring of P. aeruginosa on Agar Plates Electronic Supplementary Material (ESI) for Analytical Methods. This journal is The Royal Society of Chemistry 2015 Improved Monitoring of P. aeruginosa on Agar Plates SUPPLEMENTAL INFORMATION T. A. Webster,

More information

Verification of Gradient Diffusion Strips

Verification of Gradient Diffusion Strips Verification of Gradient Diffusion Strips Objectives 1. Describe gradient diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification

More information

User manual. Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae

User manual. Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae User manual Check-Direct CPE for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae Version 1.3 Date of issue: 24.01.2014 18-0081 48 081-04 INTENDED USE...2 INTRODUCTION

More information

IR Biotyper. Innovation with Integrity. Straight forward strain typing FT-IR

IR Biotyper. Innovation with Integrity. Straight forward strain typing FT-IR IR Biotyper Straight forward strain typing Innovation with Integrity FT-IR Strain Typing Made Easy Fast, easy-to-apply and economical typing methods are highly demanded in hospital hygiene management for

More information

Verification of Disk Diffusion Tests

Verification of Disk Diffusion Tests Verification of Disk Diffusion Tests Objectives 1. Describe disk diffusion tests 2. Describe process of FDA clearance of susceptibility tests 3. Discuss CLIA requirements for laboratory verification of

More information

Indoor air quality at selected wards at a South African government hospital. *N.J. Malebo 1 and K. Shale 2

Indoor air quality at selected wards at a South African government hospital. *N.J. Malebo 1 and K. Shale 2 Indoor air quality at selected wards at a South African government hospital *N.J. Malebo 1 and K. Shale 2 1. Central University of Technology, Bloemfontein, Republic of South Africa 2. Central University

More information

Cell Growth and DNA Extraction- Technion igem HS

Cell Growth and DNA Extraction- Technion igem HS Growing Cells and DNA Extraction Goals 1. Become familiar with the process of growing bacteria 2. Get to know the DNA extraction process 3. Perform miniprep in the lab Keywords 1. Growth stages 6. Techniques

More information

MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study

MagSi Beads. Magnetic Silica Beads for Life Science and Biotechnology study MagSi Beads Magnetic Silica Beads for Life Science and Biotechnology study MagnaMedics Diagnostics B.V. / Rev. 9.2 / 2012 Wide range of products for numerous applications MagnaMedics separation solutions

More information

Exam MOL3007 Functional Genomics

Exam MOL3007 Functional Genomics Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting

More information

Enabling Systems Biology Driven Proteome Wide Quantitation of Mycobacterium Tuberculosis

Enabling Systems Biology Driven Proteome Wide Quantitation of Mycobacterium Tuberculosis Enabling Systems Biology Driven Proteome Wide Quantitation of Mycobacterium Tuberculosis SWATH Acquisition on the TripleTOF 5600+ System Samuel L. Bader, Robert L. Moritz Institute of Systems Biology,

More information

Application Note. Authors. Abstract

Application Note. Authors. Abstract Automated, High Precision Tryptic Digestion and SISCAPA-MS Quantification of Human Plasma Proteins Using the Agilent Bravo Automated Liquid Handling Platform Application Note Authors Morteza Razavi, N.

More information

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics

6/28/2016. Control of Microbial Growth. Method. Terminology. Disinfectants and Antiseptics Control of Microbial Growth Disinfectants and Antiseptics 1 Method Three approaches for the control of microbial growth Chemical Disinfectants and antiseptics Physical Heat Ultraviolet Irradiations Mechanical

More information

Microbial Culture Collection of Cantacuzino Institute

Microbial Culture Collection of Cantacuzino Institute Microbial Culture Collection of Cantacuzino Institute Present and perspectives of development Olguta Dracea, Camelia Babes, Rodica Oancea, Anca Israil, Irina Codita, Adrian Onu, Gabriel Ionescu Cantacuzino

More information

Cloning and Characterization of E. meningoseptica Beta Lactamase

Cloning and Characterization of E. meningoseptica Beta Lactamase Cloning and Characterization of E. meningoseptica Beta Lactamase Authors: Lindsey Purcell, Jessica Matts, Patricia Canaan* Department of Biochemistry and Molecular Biology Abstract Elizabethkingia meningoseptica

More information

MicroSEQ Rapid Microbial Identification System

MicroSEQ Rapid Microbial Identification System MicroSEQ Rapid Microbial Identification System Giving you complete control over microbial identification using the gold-standard genotypic method The MicroSEQ ID microbial identification system, based

More information

Antimicrobial susceptibility testing. EUCAST disk diffusion method

Antimicrobial susceptibility testing. EUCAST disk diffusion method Antimicrobial susceptibility testing EUCAST disk diffusion method Version 2.1 February 2012 Contents Page Abbreviations and Terminology 1 Introduction 4 2 Preparation of media 5 3 Preparation of inoculum

More information

Implementation of Automated Sample Quality Control in Whole Exome Sequencing

Implementation of Automated Sample Quality Control in Whole Exome Sequencing Journal of Life Sciences 11 (2017) 261-268 doi: 10.17265/1934-7391/2017.06.001 D DAVID PUBLISHING Implementation of Automated Sample Quality Control in Whole Exome Sequencing Elisa Viering 1, Jana Molitor

More information

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF

Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF Precise Characterization of Intact Monoclonal Antibodies by the Agilent 6545XT AdvanceBio LC/Q-TOF Application Note Author David L. Wong Agilent Technologies, Inc. Santa Clara, CA, USA Introduction Monoclonal

More information

Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS

Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS 598 DOI 10.1002/prca.200600483 Proteomics Clin. Appl. 2007, 1, 598 604 TECHNICAL BRIEF Automated serum peptide profiling using novel magnetic C18 beads off-line coupled to MALDI-TOF-MS Connie R. Jimenez

More information

Proteomics. Proteomics is the study of all proteins within organism. Challenges

Proteomics. Proteomics is the study of all proteins within organism. Challenges Proteomics Proteomics is the study of all proteins within organism. Challenges 1. The proteome is larger than the genome due to alternative splicing and protein modification. As we have said before we

More information

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly

More information

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution

Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution Rapid Soft Spot Analysis using the SCIEX Routine Biotransform Solution Rapidly Identify Top Metabolites with the SCIEX X500R QTOF System and MetabolitePilot TM 2.0 Software Shaokun Pang and Ian Moore SCIEX,

More information

ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED

ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED ANTIMICROBIAL SUSCEPTIBILITY TESTING: ADVANCED Romney Humphries, Ph.D., DABMM Section Chief, Clinical Microbiology University of California Los Angeles Lost Angeles, CA Susan E. Sharp, Ph.D., DABMM, FAAM

More information

Effect of Storage of Mueller-Hinton Agar Plates on

Effect of Storage of Mueller-Hinton Agar Plates on APPUED MICROBIOLOGY, Sept. 1970, p. 293-297 Copyright 1970 American Society for Microbiology Vol. 20, No. 3 Printed in U.S.A. Effect of Storage of Mueller-Hinton Agar Plates on Zone Sizes for Antimicrobial

More information

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column

Disulfide Linkage Analysis of IgG1 using an Agilent 1260 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Disulfide Linkage Analysis of IgG1 using an Agilent 126 Infinity Bio inert LC System with an Agilent ZORBAX RRHD Diphenyl sub 2 µm Column Application Note Biotherapeutics & Biosimilars Author M. Sundaram

More information

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider

Application Note. Author. Abstract. Biopharmaceuticals. Verified for Agilent 1260 Infinity II LC Bio-inert System. Sonja Schneider Combining small-scale purification and analysis of monoclonal antibodies on one instrument Protein purification with high-volume injection using the Agilent 126 Infinity Bio-inert Quaternary LC System

More information

Creating a Culture of Data Integrity Using an Automated Detection and Enumeration Method

Creating a Culture of Data Integrity Using an Automated Detection and Enumeration Method Creating a Culture of Data Integrity Using an Automated Detection and Enumeration Method Novartis, Schaffhauserstrasse, 4332 Stein AGStein, Switzerland Sanofi Pasteur, Marcy l Etoile, France Leo Pharma,

More information

OPTIMIZATION OF BIOLOGICAL TREATMENT OF DAIRY EFFLUENT USING RESPONSE SURFACE METHODOLOGY

OPTIMIZATION OF BIOLOGICAL TREATMENT OF DAIRY EFFLUENT USING RESPONSE SURFACE METHODOLOGY Jr. of Industrial Pollution Control 33(1)(2017) pp 1106-1113 www.icontrolpollution.com Research Article OPTIMIZATION OF BIOLOGICAL TREATMENT OF DAIRY EFFLUENT USING RESPONSE SURFACE METHODOLOGY ASHA RANI

More information

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC

PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC PLRP-S Polymeric Reversed-Phase Column for LC/MS Separation of mabs and ADC Analysis of Intact and Fragmented mabs and ADC Application Note Biotherapeutics and Biologics Author Suresh Babu C.V. Agilent

More information

Dr. Rukumani Devi Velayuthan Mycology Unit Co-ordinator PPUM

Dr. Rukumani Devi Velayuthan Mycology Unit Co-ordinator PPUM Antifungal sensitivity testing using VITEK 2 Dr. Rukumani Devi Velayuthan Mycology Unit Co-ordinator PPUM VITEK 2 Systems The VITEK 2 System is intended for the automated identification and susceptibility

More information

EM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing

EM021. Co-Trimoxazole Ezy MIC TM Strip (COT)( mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing Co-Trimoxazole Ezy MIC TM Strip (COT)(0.002-32 mcg/ml) (Trimethoprim/ Sulphamethoxazole) Antimicrobial Susceptibility Testing For In Vitro Diagnostic use EM021 Not for Medicinal Use It is a unique MIC

More information

Evaluation of the BD BACTEC MGIT 320 for Detection of Mycobacteria and. Drug Susceptibility testing of Mycobacterium tuberculosis

Evaluation of the BD BACTEC MGIT 320 for Detection of Mycobacteria and. Drug Susceptibility testing of Mycobacterium tuberculosis JCM Accepts, published online ahead of print on 17 July 2013 J. Clin. Microbiol. doi:10.1128/jcm.01357-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 Evaluation

More information

Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs

Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Technical Overview Highly Confident Peptide Mapping of Protein Digests Using Agilent LC/Q TOFs Authors Stephen Madden, Crystal Cody, and Jungkap Park Agilent Technologies, Inc. Santa Clara, California,

More information

Methicillin-resistant Staphylococcus aureus (MRSA)

Methicillin-resistant Staphylococcus aureus (MRSA) TM Primerdesign Ltd Methicillin-resistant Staphylococcus aureus (MRSA) meca (penicillin binding protein 2) & S. aureus FEMB gene (chromosomal gene) genesig Advanced Kit 150 tests For general laboratory

More information

BD BBL CHROMagar CPE

BD BBL CHROMagar CPE INSTRUCTIONS FOR USE READY-TO-USE PLATED MEDIA BD BBL CHROMagar CPE PA- 257681.02 Rev. January 2017 INTENDED USE BD BBL CHROMagar CPE is a selective chromogenic screening medium for the detection of carbapenemase

More information

Empfindlichkeitstestung bei Pilzen Neuigkeiten? Bericht aus einem EUCAST AFST (yeasts and moulds) Netzwerk-Laboratorium

Empfindlichkeitstestung bei Pilzen Neuigkeiten? Bericht aus einem EUCAST AFST (yeasts and moulds) Netzwerk-Laboratorium Empfindlichkeitstestung bei Pilzen Neuigkeiten? Bericht aus einem EUCAST AFST (yeasts and moulds) Netzwerk-Laboratorium EUCAST reloaded 6.0 Follow-up Workshop 23.03.2017 Cornelia Lass-Flörl Division of

More information

STS Directory Accreditation number: STS 0268

STS Directory Accreditation number: STS 0268 International standard: ISO/IEC 17025:2005 Swiss standard: SN EN ISO/IEC 17025:2005 Bioexam AG Maihofstrasse 95a P.O.B. 6858 CH-6000 Lucerne 6 Head: Candid Bucher Responsible for MS: Nathalie Amstein Telephone:

More information

Center for Mass Spectrometry and Proteomics Phone (612) (612)

Center for Mass Spectrometry and Proteomics Phone (612) (612) Outline Database search types Peptide Mass Fingerprint (PMF) Precursor mass-based Sequence tag Results comparison across programs Manual inspection of results Terminology Mass tolerance MS/MS search FASTA

More information

LC/MS/MS Solutions for Biomarker Discovery QSTAR. Elite Hybrid LC/MS/MS System. More performance, more reliability, more answers

LC/MS/MS Solutions for Biomarker Discovery QSTAR. Elite Hybrid LC/MS/MS System. More performance, more reliability, more answers LC/MS/MS Solutions for Biomarker Discovery QSTAR Elite Hybrid LC/MS/MS System More performance, more reliability, more answers More is better and the QSTAR Elite LC/MS/MS system has more to offer. More

More information

that cannot be assigned to any known spa type

that cannot be assigned to any known spa type JCM Accepts, published online ahead of print on 2 December 2009 J. Clin. Microbiol. doi:10.1128/jcm.00933-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column

Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Size Exclusion Chromatography of Biosimilar and Innovator Insulin Using the Agilent AdvanceBio SEC column Application Note Bio-Pharmaceutical Authors M. Sundaram Palaniswamy and Andrew Coffey Agilent Technologies,

More information

FOCUS ON MRSA/SA SSTI ASSAY FAILURE IN PROSTHETIC JOINT. Institute of Microbiology, Lille University Hospital, F Lille, France

FOCUS ON MRSA/SA SSTI ASSAY FAILURE IN PROSTHETIC JOINT. Institute of Microbiology, Lille University Hospital, F Lille, France JCM Accepted Manuscript Posted Online 16 November 2016 J. Clin. Microbiol. doi:10.1128/jcm.01658-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. FOCUS ON MRSA/SA SSTI ASSAY FAILURE

More information

N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF

N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF N-Glycan Profiling Analysis of a Monoclonal Antibody Using UHPLC/FLD/Q-TOF Application Note Authors Xianming Liu, Wei Zhang, Yi Du, Sheng Yin, Hong Que, and Weichang Zhou WuXi AppTec iopharmaceuticals

More information

Efficacy Report Summarization for SoClean 2

Efficacy Report Summarization for SoClean 2 Efficacy Report Summarization for SoClean 2 October 2017 SoClean Inc 36 Town Forest Road Oxford, Massachusetts 01540 USA Tel. 508-363-0418 Email info@soclean.com SoClean 2 is USA FDA Registered 3009534409

More information

Indigo-Clean White Paper: #1 Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species. Healthcare

Indigo-Clean White Paper: #1 Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species. Healthcare Indigo-Clean White Paper: #1 Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species Healthcare HC Bactericidal Performance Testing of Indigo-Clean Upon Bacterial Species Clifford J. Yahnke,

More information

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy

Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Prevention of Transmission of the Superbug Carbapenem-Resistant Enterobacteriaceae (CRE) during Gastrointestinal Endoscopy Sponsored by: Presentation by: Lawrence F. Muscarella, Ph.D. President LFM Healthcare

More information

Developing a natural partnership for rapid, sensitive identification of binding partners

Developing a natural partnership for rapid, sensitive identification of binding partners GE Healthcare Technology Note 24 Biacore systems Developing a natural partnership for rapid, sensitive identification of binding partners Biacore 3000 and mass spectrometry Summary The coupling of label-free

More information

Conjugated protein biotherapeutics

Conjugated protein biotherapeutics B i o P r o c e s s TECHNICAL Mass Spectrometric Conjugate Characterization Process Qualification of Recombinant Protein Hapten Conjugation Miao-Fang Lin, Margo Wilson, Michael V. Murray, and Greg W. Adams

More information

Environmental Genomics and Systems Biology Institute of Natural Resource Sciences Zurich University of Applied Sciences, Wädenswil, Switzerland

Environmental Genomics and Systems Biology Institute of Natural Resource Sciences Zurich University of Applied Sciences, Wädenswil, Switzerland Environmental Genomics and Systems Biology Institute of Natural Resource Sciences Zurich University of Applied Sciences, Wädenswil, Switzerland www.zhaw.ch MALDI-TOF MS for microorganism identification:

More information

GeNei TM Transformation Teaching Kit Manual

GeNei TM Transformation Teaching Kit Manual Teaching Kit Manual Cat No. New Cat No. KT07 107385 KT07A 106220 Revision No.: 00060505 CONTENTS Page No. Objective 3 Principle 3 Kit Description 6 Materials Provided 7 Procedure 9 Observation & Interpretation

More information

6/21/2012 Speaker Hannah Wexler, PhD, Objectives Continuing Education Credit program and evaluation by 07/21/ an Archived Program 612an

6/21/2012 Speaker Hannah Wexler, PhD, Objectives Continuing Education Credit program and evaluation by 07/21/ an Archived Program 612an Anaerobic Bacteria Susceptibility Testing 6/21/2012 Speaker Hannah Wexler, PhD, Adjunct Professor, Department of Medicine UCLA School of Medicine, Los Angeles, CA Dr. Hannah Wexler is an Adjunct Professor

More information

Transmission Electron Microscopic Study of Antibiotic Action on Klebsiella pneumoniae Biofilm

Transmission Electron Microscopic Study of Antibiotic Action on Klebsiella pneumoniae Biofilm ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2002, p. 2679 2683 Vol. 46, No. 8 0066-4804/02/$04.00 0 DOI: 10.1128/AAC.46.8.2679 2683.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.

More information

Ultra High Throughput Drug Discovery Screening by MALDI-TOF Mass Spectrometry powered by Simultaneous 1536 well Pipetting

Ultra High Throughput Drug Discovery Screening by MALDI-TOF Mass Spectrometry powered by Simultaneous 1536 well Pipetting 25 Ultra High Throughput Drug Discovery Screening by MLDI-TOF Mass Spectrometry powered by Simultaneous 1536 well Pipetting Here we report the development of an automated system and workflow for ultra

More information

TechnicalNOTE METABOLYNX EXACT MASS DEFECT FILTER: RAPIDLY DISCRIMINATE BETWEEN TRUE METABOLITES AND FALSE POSITIVES INTRODUCTION

TechnicalNOTE METABOLYNX EXACT MASS DEFECT FILTER: RAPIDLY DISCRIMINATE BETWEEN TRUE METABOLITES AND FALSE POSITIVES INTRODUCTION METABOLYNX EXACT MASS DEFECT FILTER: RAPIDLY DISCRIMINATE BETWEEN TRUE METABOLITES AND FALSE POSITIVES Jose M. Castro-Perez 1, Jane Kirby 1, Laurent Leclercq 2, Claude Delatour 2, Jean-Michel Mineur 2,

More information

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing

Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing Carbapenem Resistance in Klebsiella pneumoniae Not Detected by Automated Susceptibility Testing Fred C. Tenover,* Rajinder K. Kalsi, Portia P. Williams, Roberta B. Carey,* Sheila Stocker,* David Lonsway,*

More information

ELISA for Alpha-hemolysin (Hla) in Methicilin-resistant Staphylococcus aureus (MRSA) Varandt Y. Khodaverdian 1* and Menachem Shoham 2

ELISA for Alpha-hemolysin (Hla) in Methicilin-resistant Staphylococcus aureus (MRSA) Varandt Y. Khodaverdian 1* and Menachem Shoham 2 ELISA for Alpha-hemolysin (Hla) in Methicilin-resistant Staphylococcus aureus (MRSA) Varandt Y. Khodaverdian 1* and Menachem Shoham 2 1 Department of Biology, Tufts University, Medford, USA; 2 Department

More information

Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany

Technical Overview. Author. Abstract. Edgar Naegele Agilent Technologies, Inc. Waldbronn, Germany New Features of the Agilent Method Scouting Wizard for Automated Method Development of Complex Samples Analysis of Large Data Sets by Method Scouting Reports and Automated Adjustment of Flow Rates and

More information

Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct.

Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite. Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. Monoclonal Antibody Characterization on Q Exactive and Oribtrap Elite Yi Zhang, Ph.D Senior Proteomic Marketing Specialist Oct. 12, 211 Outline Orbitrap Mass Spectrometer in mab Characterization Intact

More information

Glycopeptide antibiotics, particularly vancomycin, have for

Glycopeptide antibiotics, particularly vancomycin, have for Use of Matrix-Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry To Identify Vancomycin-Resistant Enterococci and Investigate the Epidemiology of an Outbreak Paul M. Griffin, a Gareth

More information

QUALITY CONTROL FOR AST: IQCP? Romney Humphries UCLA

QUALITY CONTROL FOR AST: IQCP? Romney Humphries UCLA QUALITY CONTROL FOR AST: IQCP? Romney Humphries UCLA WHAT IS QUALITY CONTROL? Procedures used to detect errors that occur due to: test system failure adverse environmental conditions variance in operator

More information

Dentistry Test methods for dental unit waterline biofilm treatment

Dentistry Test methods for dental unit waterline biofilm treatment Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 16954 First edition 2015-07-01 Dentistry Test methods for dental unit waterline biofilm treatment Médecine bucco-dentaire Méthodes d essais pour

More information

Pristinamycin. Damocles 2015

Pristinamycin. Damocles 2015 Pristinamycin Damocles 2015 Pristinamycin is an oral antibiotic deriving from Streptomyces pristinaespiralis, a Gram-positive bacteria of the genus streptomyces. 1 It is used as therapeutic to treat infections

More information

Proteomics And Cancer Biomarker Discovery. Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar. Overview. Cancer.

Proteomics And Cancer Biomarker Discovery. Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar. Overview. Cancer. Proteomics And Cancer Biomarker Discovery Dr. Zahid Khan Institute of chemical Sciences (ICS) University of Peshawar Overview Proteomics Cancer Aims Tools Data Base search Challenges Summary 1 Overview

More information

Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors

Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Contact Us: www.pall.com/contact Dynamic High Capacity Mustang Q Membrane Units for Scaleable Anion Exchange Chromatography Purification of Adenoviral Vectors Dynamic High Capacity Mustang Q Membrane Units

More information

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017

A2LA. R231 Specific Requirements: Threat Agent Testing Laboratory Accreditation Program. December 6, 2017 Laboratory Page 1 of 17 Laboratory December 6, 2017 2017 by A2LA All rights reserved. No part of this document may be reproduced in any form or by any means without the prior written permission of A2LA.

More information

Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen

Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Evaluation of a Novel Non-Sterile Glove Dispensing System Uyen Nguyen Edited by: Michael Diamond Reviewed by: Andrew Duong Disclaimer: The author of this report and declare no conflict of interest with

More information

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona

Application Note. Kwasi Antwi, Amanda Ribar, Urban A. Kiernan, and Eric E. Niederkofler Thermo Fisher Scientific, Tempe, Arizona Analysis of an Antibody Drug Conjugate using MSIA D.A.R.T. S. Technology, an Integral Part of Ligand Binding Mass Spectrometric Immunoassay (LB-MSIA) Workflow Application Note Kwasi Antwi, Amanda Ribar,

More information

Minimum Inhibitory Concentration (MIC) Assay for Antifungal Drugs

Minimum Inhibitory Concentration (MIC) Assay for Antifungal Drugs Minimum Inhibitory Concentration (MIC) Assay for Antifungal Drugs Jinglin L. Xie 1, Sheena D. Singh-Babak 2 and Leah E. Cowen 2* 1 Molecular Genetics, University of Toronto, Toronto, Canada; 2 Department

More information

The biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush

The biomérieux solution. VITEK2 : A challenge with ESBL ESBL. Karen Bush International Newsletter n 4 December 2003 Through the IDENTIFYING RESISTANCE Newsletter, biomérieux s ambition is to contribute to the awareness and progress in the field of resistance to antibiotics.

More information

User manual. Check-Direct CPE. Screen for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae

User manual. Check-Direct CPE. Screen for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae User manual Check-Direct CPE Screen for BD MAX Real time PCR kit for the detection of carbapenemase-producing Enterobacteriaceae Version 1.0 Date of issue: 09.09.2014 18-0051 24 51-01 EU: U.S.: For Research

More information

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS

CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS CONTROL OF MICROBIAL GROWTH - DISINFECTANTS AND ANTISEPTICS Specific control measures can be used to kill or inhibit the growth of microorganisms. A procedure which leads to the death of cells is broadly

More information

Mouse Factor XII Total ELISA Kit

Mouse Factor XII Total ELISA Kit Mouse Factor XII Total ELISA Kit Catalog No: IMFXIIKT-TOT Lot No: SAMPLE INTENDED USE This mouse coagulation Factor XII antigen assay is intended for the quantitative determination of total Factor XII

More information

Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group

Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group Journal of Antimicrobial Chemotherapy (99) 7, 599-606 Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group J. A. Garcia-Rodriguez, J. E. Garcia Sanchez,

More information

Investigating Biological Variation of Liver Enzymes in Human Hepatocytes

Investigating Biological Variation of Liver Enzymes in Human Hepatocytes Investigating Biological Variation of Liver Enzymes in Human Hepatocytes SWATH Acquisition on the TripleTOF Systems Xu Wang 1, Hui Zhang 2, Christie Hunter 1 1 SCIEX, USA, 2 Pfizer, USA MS/MS ALL with

More information

Human IL-6 ELISA. For the quantitative determination of IL-6 in human cell culture supernates, serum and plasma (heparin, EDTA, citrate)

Human IL-6 ELISA. For the quantitative determination of IL-6 in human cell culture supernates, serum and plasma (heparin, EDTA, citrate) K-ASSAY Human IL-6 ELISA For the quantitative determination of IL-6 in human cell culture supernates, serum and plasma (heparin, EDTA, citrate) Cat. No. KT-1348 For Research Use Only. Not for diagnostic

More information

Converting your ELISA from horseradish peroxidase to alkaline phosphatase using NovaBright chemiluminescence detection reagents

Converting your ELISA from horseradish peroxidase to alkaline phosphatase using NovaBright chemiluminescence detection reagents Application note DynaLight Substrate with RapidGlow Enhancer Converting your ELISA from horseradish peroxidase to alkaline phosphatase using NovaBright chemiluminescence detection reagents Introduction

More information

The role of PHE s AMRHAI Reference Unit

The role of PHE s AMRHAI Reference Unit The role of PHE s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright What does AMRHAI offer? Susceptibility

More information

Featuring Analyst software under Windows NT for enhanced performance and ease of use. API 150EX. LC/MS System

Featuring Analyst software under Windows NT for enhanced performance and ease of use. API 150EX. LC/MS System Featuring Analyst software under Windows NT for enhanced performance and ease of use. API 15EX LC/MS System compact, rugged, The API 15EX LC/MS System is the most rugged and reliable single quadrupole

More information

Title: Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR

Title: Detection of carbapenemases in Enterobacteriaceae by a commercial multiplex PCR JCM Accepts, published online ahead of print on 11 July 2012 J. Clin. Microbiol. doi:10.1128/jcm.00991-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11

More information

EVALUATION OF DIFFERENT PRIMERS FOR DETECTING

EVALUATION OF DIFFERENT PRIMERS FOR DETECTING SOUTHEAST ASIAN J TROP MED PUBLIC HEALTH EVALUATION OF DIFFERENT PRIMERS FOR DETECTING MECA GENE BY PCR IN COMPARISON WITH PHENOTYPIC METHODS FOR DISCRIMINATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS

More information

Human IgG ELISA Quantitation Set

Human IgG ELISA Quantitation Set Human IgG ELISA Quantitation Set Cat. No. E80-104 Components Supplied Affinity purified Goat anti-human IgG-Fc Coating Antibody A80-104A, 1 ml at 1 mg/ml Human Reference Serum, RS10-110-4, 0.1 ml HRP Conjugated

More information

Flow cytometry tools for characterization of GMP cell products

Flow cytometry tools for characterization of GMP cell products Flow cytometry tools for characterization of GMP cell products Alexandra Rizzitelli, PhD Project manager Cell therapies Pty Ltd, Melbourne, Australia What is product characterization? Identity (phenotype)

More information

ab65354 Superoxide Dismutase Activity Assay kit (Colorimetric)

ab65354 Superoxide Dismutase Activity Assay kit (Colorimetric) Version 9 Last updated 11 January 2018 ab65354 Superoxide Dismutase Activity Assay kit (Colorimetric) For the measurement of Superoxide Dismutase Activity in various samples. This product is for research

More information

Quantify protein stability with ΔG

Quantify protein stability with ΔG Technical Note Quantify protein stability with ΔG Introduction Biologics stability determinations often rely on forced degradation methods to rank constructs or optimize formulations. The most well-established

More information

SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM

SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM SNP GENOTYPING Accurate, sensitive, flexible MassARRAY System SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM Biomarker validation Routine genetic testing Somatic mutation profiling Up to 400

More information

Bye-Bye Biochemicals:

Bye-Bye Biochemicals: Bye-Bye Biochemicals: How New Technology is Revolutionizing Microbiology Kevin Alby Ph.D., D(ABMM), MLS(ASCP) Assistant Director Clinical Microbiology Laboratory, Hospital of the University of Pennsylvania

More information

A Sub-picogram Quantification Method for Desmopressin in Plasma using the SCIEX Triple Quad 6500 System

A Sub-picogram Quantification Method for Desmopressin in Plasma using the SCIEX Triple Quad 6500 System A Sub-picogram Quantification Method for Desmopressin in Plasma using the SCIEX Triple Quad 6500 System A high-throughput method for detecting ultra-low levels (0.5 pg/ml) of a therapeutic peptide in human

More information